Mutations of the epidermal growth factor receptor (EGFR) gene play a critical role in carcinogenesis of lung cancer, particularly adenocarcinoma. However, to the best of our knowledge, no mutations of the EGFR in patients with lung carcinosarcoma have been identified. We herein report the case of a 61-year-old female referred for a detailed examination of a left pulmonary mass shadow. Although bronchoscopy was performed, it failed to lead to a diagnosis, and video-assisted thoracoscopic surgery was therefore carried out to diagnose the tumor. The pathology revealed biphasic features consisting of both adenocarcinoma and chondrosarcoma. Intriguingly, both the adenocarcinoma and chondrosarcoma components were proven to harbor an exon19 deletion in the EGFR gene. Although carcinosarcoma is a rare malignancy of the lungs, genetic analyses of oncogenic drivers, such as the EGFR gene, should be conducted. (c) 2013 Elsevier Ireland Ltd. All rights reserved.

The first case of lung carcinosarcoma harboring in-frame deletions at exon19 in the EGFR gene / Toyokawa, G; Takenoyama, M; Taguchi, K; Arakaki, K; Inamasu, E; Toyozawa, R; Kojo, M; Shiraishi, Y; Morodomi, Y; Takenaka, T; Hirai, F; Yamaguchi, M; Seto, T; Leone, A; Graziano, P; Ichinose, Y. - In: LUNG CANCER. - ISSN 0169-5002. - 81:3(2013), pp. 491-494. [10.1016/j.lungcan.2013.06.013]

The first case of lung carcinosarcoma harboring in-frame deletions at exon19 in the EGFR gene

Graziano P
Penultimo
;
2013

Abstract

Mutations of the epidermal growth factor receptor (EGFR) gene play a critical role in carcinogenesis of lung cancer, particularly adenocarcinoma. However, to the best of our knowledge, no mutations of the EGFR in patients with lung carcinosarcoma have been identified. We herein report the case of a 61-year-old female referred for a detailed examination of a left pulmonary mass shadow. Although bronchoscopy was performed, it failed to lead to a diagnosis, and video-assisted thoracoscopic surgery was therefore carried out to diagnose the tumor. The pathology revealed biphasic features consisting of both adenocarcinoma and chondrosarcoma. Intriguingly, both the adenocarcinoma and chondrosarcoma components were proven to harbor an exon19 deletion in the EGFR gene. Although carcinosarcoma is a rare malignancy of the lungs, genetic analyses of oncogenic drivers, such as the EGFR gene, should be conducted. (c) 2013 Elsevier Ireland Ltd. All rights reserved.
2013
Lung carcinosarcoma; Lung sarcomatoid carcinoma; Epidermal growth factor; receptor Oncogenic drivers; Molecular-targeted therapy; EGFR-TKI
01 Pubblicazione su rivista::01i Case report
The first case of lung carcinosarcoma harboring in-frame deletions at exon19 in the EGFR gene / Toyokawa, G; Takenoyama, M; Taguchi, K; Arakaki, K; Inamasu, E; Toyozawa, R; Kojo, M; Shiraishi, Y; Morodomi, Y; Takenaka, T; Hirai, F; Yamaguchi, M; Seto, T; Leone, A; Graziano, P; Ichinose, Y. - In: LUNG CANCER. - ISSN 0169-5002. - 81:3(2013), pp. 491-494. [10.1016/j.lungcan.2013.06.013]
File allegati a questo prodotto
File Dimensione Formato  
1-s2.0-S0169500213002705-main.pdf

solo gestori archivio

Note: Toyokawa_The first case_2013
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 1.38 MB
Formato Adobe PDF
1.38 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1704513
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 10
social impact